Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive nonsyndromic deafness in which the cause of the disease is a mutation in the TMC1 gene.
Features include: Abnormal vestibular function and Inner ear hearing loss (sensorineural hearing impairment).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 2 | Abnormal vestibular function, Inner ear hearing loss (sensorineural hearing impairment) |
TMC1 function has not been fully characterized.
Autosomal recessive nonsyndromic hearing loss 7 is caused by mutations in the TMC1 gene on chromosome 9.
Genetic testing for TMC1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal recessive nonsyndromic hearing loss 7 has been reported in the published literature.
No clinical trials have been registered for autosomal recessive nonsyndromic hearing loss 7.
40 publications have been identified in PubMed for autosomal recessive nonsyndromic hearing loss 7. Research spans Basic Science / Preclinical (28%), Epidemiology / Natural History (25%), and Gene Therapy / Novel Therapeutics (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 11 | 28% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Disease patterns and progression |
10 |
25% |
New treatment approaches | 7 | 18% |
Patient case studies | 6 | 15% |
Testing and diagnosis research | 3 | 8% |
Research summaries | 2 | 5% |
Clinical study results | 1 | 3% |
Hoang NC (2026). [PMID: 41955303](https://pubmed.ncbi.nlm.nih.gov/41955303/). *Hum Mol Genet*. [Epidemiology / Natural History]
Pshennikova VG (2026). [PMID: 40957967](https://pubmed.ncbi.nlm.nih.gov/40957967/). *Journal of human genetics*. [Case Report / Case Series]
Abati E (2026). [PMID: 42089726](https://pubmed.ncbi.nlm.nih.gov/42089726/). *J Neuromuscul Dis*. [Review / Meta-Analysis]
Chan KH (2026). [PMID: 41623227](https://pubmed.ncbi.nlm.nih.gov/41623227/). *The Laryngoscope*. [Epidemiology / Natural History]
Boespflug-Tanguy O (2026). [PMID: 42198847](https://pubmed.ncbi.nlm.nih.gov/42198847/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Xia XX (2026). [PMID: 41763034](https://pubmed.ncbi.nlm.nih.gov/41763034/). *Stem Cell Res*. [Basic Science / Preclinical]
Zhang L (2025). [PMID: 40409265](https://pubmed.ncbi.nlm.nih.gov/40409265/). *Med (New York, N.Y.)*. [Gene Therapy / Novel Therapeutics]
Marucci A (2025). [PMID: 40603556](https://pubmed.ncbi.nlm.nih.gov/40603556/). *Diabetologia*. [Epidemiology / Natural History]
Halabi I (2025). [PMID: 39944315](https://pubmed.ncbi.nlm.nih.gov/39944315/). *Frontiers in pediatrics*. [Basic Science / Preclinical]
Toure M (2025). [PMID: 39092543](https://pubmed.ncbi.nlm.nih.gov/39092543/). *Annals of human genetics*. [Epidemiology / Natural History]